Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/24/2869144/0/en/NANOBIOTIX-Provides-Business-Update-and-Reports-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2024/04/17/2864968/0/en/NANOBIOTIX-to-Announce-Fourth-Quarter-and-Full-Year-2023-Operational-and-Financial-Update-on-April-24-2024.html
https://www.globenewswire.com/news-release/2024/04/02/2856479/0/en/Nanobiotix-Announces-Completion-of-Phase-1-Dose-Escalation-and-NBTXR3-Recommended-Phase-2-Dose-for-the-Treatment-of-Inoperable-Recurrent-Lung-Cancer-in-Patients-Amenable-to-Re-Irra.html
https://www.globenewswire.com//news-release/2024/03/06/2841787/0/en/Nanobiotix-to-Present-at-Upcoming-Investor-Conferences-in-March.html
https://www.globenewswire.com//news-release/2024/02/13/2828661/0/en/Voting-Rights-and-Shares-Capital-of-the-Company.html
https://www.globenewswire.com/news-release/2024/01/31/2821565/0/en/Nanobiotix-to-Present-at-the-Guggenheim-6th-Annual-Biotechnology-Conference.html
https://www.globenewswire.com/news-release/2024/01/29/2819438/0/en/Nanobiotix-Announces-Achievement-of-20M-Development-Milestone-Payment-Related-to-Ongoing-Global-Phase-3-Head-and-Neck-Cancer-Study.html
https://www.globenewswire.com//news-release/2024/01/11/2808363/0/en/Voting-Rights-and-Shares-Capital-of-the-Company.html
https://www.globenewswire.com/news-release/2023/12/26/2801026/0/en/Nanobiotix-Partner-LianBio-Assigns-Its-Development-and-Commercialization-Rights-for-NBTXR3-in-China-and-Other-Asian-Markets.html
https://www.globenewswire.com//news-release/2023/12/13/2795880/0/en/Voting-Rights-and-Shares-Capital-of-the-Company.html